Denali Therapeutics Inc (NASDAQ:DNLI)
| 23.30 Delayed Data As of May 24 |  -1.15 / -4.71%Today’s Change | 20.24 Today|||52-Week Range 79.70 | -47.76% Year-to-Date |
Latest DNLI News | Press Releases
No recent news for Denali Therapeutics Inc.
Today’s Trading
| Previous close | 24.40 |
| Today’s open | 24.10 |
| Day’s range | 22.73 - 24.10 |
| Volume | 454,937 |
| Average volume (3 months) | 588,228 |
| Market cap | $3.0B |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | -466.28% |
| Earnings growth (this year) | -10.31% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -85.50% |
| P/E ratio | NM |
| Price/Sales | 111.38 |
| Price/Book | 3.14 |
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.57 |
| Annual revenue (last year) | $48.7M |
| Annual profit (last year) | -$290.6M |
| Net profit margin | -597.15% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
